Invest in Neurocarrus: Treating Neurodegenerative Disease and Pain Without Addiction

1

Drug candidate N-001 provides relief from acute pain in animals caused by inflammation or surgery.

2

Neurocarrus has built a pipeline of drugs using the APOLLO targeting and delivery system.

3

N-001, NL-17, N-19a treat acute, migraine and chronic pain by sensory neuron targeting.

4

The APOLLO drugs use a unique manufacturing process to discourage competitors.

5

There is a massive market for the treatment of Neurodegenerative disease and pain around the world.

6

Neurocarrus has a strong track record of non-dilutive funding from federal and state government.

7

Founder has been working in the space for 25+ years trouble shooting commercial biologicals.

8

Patents issued and pending on exclusively licensed technology in both the U.S. and select countries.

Invest in Neurocarrus